CELC · Company research
Celcuity Inc. Common Stock (CELC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
24records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| CELC Dec 2026 135.000 call (CELC261218C00135000) interactive stock chart - Yahoo Finance UK | CELC Dec 2026 135.000 call (CELC261218C00135000) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 16, 2026 | neutral | 0 | 0.6 |
| CELC Oct 2026 115.000 call (CELC261016C00115000) stock historical prices and data - Yahoo Finance UK | CELC Oct 2026 115.000 call (CELC261016C00115000) stock historical prices and data Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 16, 2026 | neutral | 0 | 0.6 |
| Celcuity Inc. (CELC) Stock Price, News, Quote & History - Yahoo! Finance Canada | Celcuity Inc. (CELC) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| CELC Stock Jumps After Hours On Positive Breast Cancer Trial Data - Stocktwits | CELC Stock Jumps After Hours On Positive Breast Cancer Trial Data Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| RIVN Stock Climbs Despite Lucid Bankruptcy Rumors As Morgan Stanley Lifts Price Target - Stocktwits | RIVN Stock Climbs Despite Lucid Bankruptcy Rumors As Morgan Stanley Lifts Price Target Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| New Strong Sell Stocks for October 14th | Zacks has added three stocks to its Strong Sell list: adidas AG with a 5.1% downward earnings revision, Celcuity Inc. with a 15.3% downward revision, and Collective Mining Ltd. with a 31.8% downward earnings revision over the last 60 days. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bearish | -1 | 1 |
| New Strong Sell Stocks for October 14th | Zacks has added three stocks to its Strong Sell list: adidas AG with a 5.1% downward earnings revision, Celcuity Inc. with a 15.3% downward revision, and Collective Mining Ltd. with a 31.8% downward earnings revision over the last 60 days. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | bearish | -1 | 1 |
| how InvestingPro’s Fair Value flagged Celcuity’s 52% decline By Investing.com - Investing.com | how InvestingPro’s Fair Value flagged Celcuity’s 52% decline By Investing.com Investing.com | View source ↗ | Investing.com | Oct 13, 2026 | neutral | 0 | 0.6 |
| Precision Trading with Celcuity Inc. (CELC) Risk Zones - Stock Traders Daily | Precision Trading with Celcuity Inc. (CELC) Risk Zones Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 11, 2026 | neutral | 0 | 0.6 |
| Does REVTORPYK Launch Change The Bull Case For Celcuity Stock? - Simply Wall Street | Does REVTORPYK Launch Change The Bull Case For Celcuity Stock? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 10, 2026 | neutral | 0 | 0.6 |
| CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug - Stocktwits | CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug Stocktwits | View source ↗ | Stocktwits | Oct 8, 2026 | neutral | 0 | 0.6 |
| Celcuity Inc. (CELC) stock price, news, quote and history - Yahoo Finance Singapore | Celcuity Inc. (CELC) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 8, 2026 | neutral | 0 | 0.6 |
| Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News Event - Yahoo Finance | Celcuity (CELC) Is Down 17.3% After REVTORPYK US Launch And sNDA Filing News Event Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| CELC Oct 2026 130.000 call (CELC261016C00130000) stock historical prices and data - Yahoo Finance UK | CELC Oct 2026 130.000 call (CELC261016C00130000) stock historical prices and data Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 7, 2026 | neutral | 0 | 0.6 |
| CELC Jan 2028 60.000 put (CELC280121P00060000) stock price, news, quote and history - Yahoo Finance Australia | CELC Jan 2028 60.000 put (CELC280121P00060000) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 7, 2026 | neutral | 0 | 0.6 |
| CELC Oct 2026 75.000 call (CELC261016C00075000) interactive stock chart - Yahoo Finance UK | CELC Oct 2026 75.000 call (CELC261016C00075000) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 7, 2026 | neutral | 0 | 0.6 |
| CELC Oct 2026 130.000 call (CELC261016C00130000) interactive stock chart - Yahoo Finance UK | CELC Oct 2026 130.000 call (CELC261016C00130000) interactive stock chart Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 7, 2026 | neutral | 0 | 0.6 |
| CELC Jan 2027 135.000 put (CELC270115P00135000) Interactive Stock Chart - Yahoo! Finance Canada | CELC Jan 2027 135.000 put (CELC270115P00135000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Celcuity (CELC) Dropped, So What Is Behind Its Latest Move? - Yahoo Finance | Celcuity (CELC) Dropped, So What Is Behind Its Latest Move? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 3, 2026 | neutral | 0 | 0.6 |
| Why Celcuity Stock Was a Winner on Wednesday | Celcuity stock gained 2.8% on Wednesday as the biotech company launched its first FDA-approved drug, Revtorpyk, for HR+/HER2 breast cancer treatment. The company also introduced support services for patients and physicians. The stock outperformed the broader market, which saw the S&P 500 decline 0.3%. | View source ↗ | The Motley Fool | Sep 30, 2026 | bullish | 1 | 1 |
| Is Celcuity (CELC) Stock a Buy? - Yahoo Finance | Is Celcuity (CELC) Stock a Buy? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 27, 2026 | neutral | 0 | 0.6 |
| Why CELC Stock Declined 15% in a Week Despite a Major FDA Win - Zacks Investment Research | Why CELC Stock Declined 15% in a Week Despite a Major FDA Win Zacks Investment Research | View source ↗ | Zacks Investment Research | Jul 21, 2026 | neutral | 0 | 0.6 |
| Why CELC Stock Declined 15% in a Week Despite a Major FDA Win - TradingView | Why CELC Stock Declined 15% in a Week Despite a Major FDA Win TradingView | View source ↗ | TradingView | Jul 21, 2026 | neutral | 0 | 0.6 |
| Celcuity (CELC) Stock May Be Overvalued After REVTORPYK Approval - Webull | Celcuity (CELC) Stock May Be Overvalued After REVTORPYK Approval Webull | View source ↗ | Webull | Jul 18, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.